| Trial ID: | L0543 |
| Source ID: | NCT00151931
|
| Associated Drug: |
Lanthanum Carbonate
|
| Title: |
Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic
|
| Interventions: |
DRUG: Lanthanum carbonate
|
| Outcome Measures: |
Primary: Change in pre-dialysis serum phosphate levels at Week 3 compared with Week 5, Week 3 and Week 5 | Secondary: Treatment emergent adverse events, Throughout the study period of approximately 20 months.
|
| Sponsor/Collaborators: |
Sponsor: Shire
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
456
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-05-11
|
| Completion Date: |
2006-01-12
|
| Results First Posted: |
|
| Last Update Posted: |
2021-06-08
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00151931
|
